One rehabilitated manatee from the Cincinnati Zoo & Botanical Garden and two from the Columbus Zoo and Aquarium have returned to Florida, and new manatees in need of tender loving care are now receiving attention from the animal experts at the two Ohio facilities.
Groundbreaking, Scientific Study Provides New Research to Better Understand, Enhance Zoo Elephant Welfare. “Using Science to Understanding Zoo Elephant Welfare” is the largest and most comprehensive, multi-institution study ever conducted to collect and assess data on the welfare of any species in North American zoos.
The Alliance of Marine Mammal Parks and Aquariums (AMMPA), the international association for marine mammal facilities and global conservation and research organizations, announced today the appointment of Kathleen Dezio as executive director. Dezio is a senior association executive with more than 25 years of experience in association management, public affairs and communications. The appointment is effective immediately.
Researchers Report Benefits Of Drug-Coated Balloons "“ In a new approach to drug-coating without the stent, scientists successfully used drug-coated angioplasty balloons in minimally invasive procedures to open narrowed and blocked blood vessels in the legs.
Ultrasound transducers are a new device to dissolve clots faster, more easily and more safely than the conventional technique. A study finds the devices are more effective at dissolving blood clots in leg and pelvic arteries, and more than twice as effective in thigh veins (DVT).
The 2004 GlaxoSmithKline Drug Discovery and Development Research Grants have recently been awarded to three scientists working on novel approaches to combat HIV, the virus that causes AIDS.
Physicians are seeing more and more infections caused by drug-resistant bacteria in healthy people. One such bug, methicillin-resistant Staphylococcus aureus, is causing exponentially increasing cases of skin boils in children.
Walk into a New York City store that primarily serves the Hispanic community and you'll likely be able to purchase antibiotics without a prescription. In this country, purchasing those drugs without a prescription is illegal, and contributes to the growing worldwide problem of drug-resistant bacteria.
Alcohol-based hand sanitizers are great germ-killers, and may a stop stomach bug that comes home with junior from felling the whole family. Families that used sanitizer gel had a 59 percent reduction in the spread of gastrointestinal illnesses compared with families that didn't use sanitizer.
Researchers have found that women who take AIDS drugs may pass along high levels of the medication through breast-feeding, potentially providing a "two-for-one" situation in which moms can be treated for the illness and their infants are protected from contracting it.
New research shows that elephants in professionally managed zoological facilities have life expectancies similar to elephants in the wild. The finding refutes a 2002 study that claimed wild elephants typically live longer.
The old wives' tale is evidently true: cranberry juice cocktail helps ward off urinary tract infections. Now comes new evidence that drinking eight ounces of the tart juice works better than four.
EPZICOM(tm), a new product combining two HIV medicines into one tablet dosed once a day (QD) with no food or fluid requirements, was cleared for prescription use today by the U.S. Food and Drug Administration (FDA).
GSK is announcing a call for applications for its 2004 Drug Discovery and Development Research Grant Program. GSK will award $250,000 in grants for innovative HIV/AIDS drug research in recognition of the need to produce new alternatives and hope in the fight against HIV/AIDS.
Five researchers have been awarded 2003 GlaxoSmithKline (GSK) Drug Discovery and Development Research Grants for their efforts to develop new pharmaceutical strategies to combat HIV, the virus that causes AIDS.
GlaxoSmithKline today announced that the FDA has granted marketing clearance for Lexivaâ„¢ (fosamprenavir calcium) (Lex-ee'-va, formerly GW433908, or 908), a new protease inhibitor (PI) for the treatment of HIV infection in adults in combination with other antiretroviral medications.
Studies supporting the efficacy of a once daily (QD) antiretroviral (ART) therapy regimen and the QD dosing of Ziagen® (abacavir sulfate) (ABC) were presented here today.
In a study comparing TDF vs. EFV (both given with 3TC and ABC), 49 percent of patients in the TDF arm experienced early virologic non-response, compared with 5 percent of patients in the EFV arm at week 8.
Pharmacokinetic (PK) data from two clinical studies of the investigational HIV protease inhibitor (PI) 433908 (908) were presented today. The studies were conducted to evaluate the interactions of 908 with medications commonly used for heartburn and lipid disorders.
A treatment regimen of Ziagen® (abacavir sulfate), Epivir® (lamivudine) (3TC) and efavirenz (EFV) has been shown to be non-inferior to the often prescribed regimen of Retrovir® (zidovudine) and 3TC and EFV in a large Phase III clinical trial comparing virologic response in treatment-naïve HIV+ adults.
Elderly health concerns such as Alzheimer's disease will be among the major topics of scientific presentations at the International Psychogeriatric Association 11th International Congress. Psychiatrists, geriatricians, nurses and allied health professionals from around the world will participate in the Congress.
Preliminary 24-week data were presented today from the CONTEXT trial, an open-label, multi-center study evaluating the safety and efficacy of once-a-day (QD) or twice-a-day (BID) dosing of the investigational protease inhibitor (PI) GW433908 (908) boosted with ritonavir (908/r) compared to a third treatment arm with the PI lopinavir/ritonavir (LPV/r, Kaletra(r)) BID in treatment-experienced patients with prior virologic failure.
Final 48-week results from the NEAT trial, an open-label, multi-center study evaluating the safety and efficacy of the investigational protease inhibitor (PI) GW433908 (908) in antiretroviral therapy-naive HIV+ patients versus nelfinavir (NFV/Viracept (r)), were presented here today. In the trial, 66 percent of 166 HIV+ patients (n=109) achieved an undetectable viral load (vRNA) with 908, compared to 51 percent of 83 patients (n=42) taking nelfinavir.
The results from a longitudinal study of the relative frequency of various types of HIV mutations associated with the use of antiretroviral therapy were presented today at a meeting of leading AIDS researchers.
Forty-eight-week data were presented here today from two Phase III studies of treatment-naive patients with HIV infection, evaluating the resistance profile of the investigational protease inhibitor GW433908 (908) dosed twice a day (BID) or 908 boosted with the PI ritonavir (908/r) dosed once a day (QD) compared to the PI nelfinavir (NFV) BID.
Results of the SOLO trial, an open-label, multi-center study evaluating the safety and efficacy of once-a-day dosing of the investigational protease inhibitor GW433908 (908) boosted with ritonavir (908/r) QD in antiretroviral therapy-naive patients versus twice-a-day nelfinavir, were presented today.
Safety should be a major consideration as you search for the perfect gift for your children this holiday season.
Parents need to teach their kids that it truly is better to give than to receive. A case of the gimmies is not a cause for panic. It is important for kids to pay attention to the self, but also to pay attention to others.
The total number of pills that need to be taken every day in HAART therapy has the greatest impact on adherence of 10 characteristics studied, according to a survey of HIV positive individuals, nearly two-thirds of whom had experienced at least three treatment regimens.
Several medals may have been salvaged with the help of a strategy for detection and treatment of the flu at the Salt Lake City Winter Olympics. The strategy was possible because of the recent availability of rapid flu tests and anti-viral medication.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right